Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Ivo Lemmens
Person

Ivo Lemmens

Tracked across 2 events · 15 articles · First seen May 27, 2026 · Last active Jun 08, 2026

Sentiment
0
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 0
Regulatory
Intravacc receives French CIR approval
Intravacc, a global CDMO specializing in vaccine and biologics development, has received approval from the Oman — Ministry of Higher Education, Science, Research and Innovation for the French Research Tax Credit (CIR) for the years…
Impact: Ivo Lemmens, Intravacc's managing director, expressed satisfaction with the CIR approval, highlighting its support for accelerating vaccine innovation and reducing development risk for French and European partners.
May 27, 2026 · 6 articles
2 0
Business
Intravacc expands analytical services
Intravacc, a leading global contract development and manufacturing organization, has announced an expanded commercial focus on integrated analytical services for vaccine and biologics developers. These services aim to support partners from product characterization and assay…
Impact: Ivo Lemmens, Intravacc's managing director, provided a statement emphasizing the importance of robust analytics in vaccine development and Intravacc's role in it.
Jun 08, 2026 · 9 articles
NEWSDESK
Track Ivo Lemmens live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.